• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

32.9300 USD 0.2000 0.61%

As of 15:49:10 ET on 08/27/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 32.8400 Day's Range: 32.3500 - 33.2200 Volume: 324,387
Previous Close: 32.7300 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: -1.46%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 32.9300
  • 1D
  • 1M
  • 1Y
32.7300
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 70.9951
Estimated P/E(12/2014) 33.3806
Relative P/E vs. SPX 3.9504
Earnings Per Share (USD) (ttm) 0.4645
Est. EPS (USD) (12/2014) 0.9880
Est. PEG Ratio 0.7418
Market Cap (M USD) 1,376.75
Shares Outstanding (M) 41.74
30 Day Average Volume 434,489
Price/Book (mrq) 2.7071
Price/Sale (ttm) 3.7855
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil